We conducted field and laboratory experiments to evaluate whether treating pregnant bighorn ewes with a combination of an experimental Pasteurella trehalosi and Mannheimia haemolytica (formerly P. haemolytica) vaccine and a commercially-available bovine P. multocida and M. haemolytica vaccine would increase lamb survival following a pneumonia epidemic. Three free-ranging bighorn herds affected by pasteurellosis outbreaks between November 1995 and June 1996 were included in the field experiment. Post-epidemic lamb survival was low in all three herds in 1996, with November lamb:ewe ratios of Յ8:100. In March 1997, thirty-six ewes (12/ herd) were captured and radiocollared. Half of the ewes captured in each herd were randomly selected to receive both vaccines; the other half were injected with 0.9% saline solution as controls. Lambs born to radiocollared ewes were observed two or more times per week and were considered to have survived if they were alive in October 1997, about 6 mo after birth. Lamb survival differed among herds (range 22% to 100%), and survival of lambs born to vaccinated ewes was lower (P ϭ 0.08) than survival of lambs born to unvaccinated ewes. Bronchopneumonia (pasteurellosis) was the dominant cause of mortality among lambs examined. We concurrently evaluated vaccine effects on survival of lambs born to seven captive ewes removed from the wild during the 1995-96 epidemic. Antibody titers were high in captive ewes prior to vaccination, and vaccines failed to enhance antibody titers in treated captive ewes. None of the captive-born lambs survived. These data suggest that, using existing technology, vaccinating bighorn ewes following pneumonia epidemics has little chance of increasing neonatal survival and population recovery.
We studied survival of elk (Cervus elaphus) ≥1 yr old and quantified mortality sources in the Blue Mountains of Washington, 2003–2006, following a period of extensive poaching. The population was managed under a spike‐only general hunting season, with limited permits for larger males and for females. We radiomarked 190 elk (82 males and 39 females >1 yr old and 65 males 11 months old), most with rumen transmitters and neck radiocollars; 60 elk only received rumen transmitters. We estimated annual survival using known fate models and explored survival differences among sex and age classes and in 2 potentially different vulnerability zones for males. We found little support for differences in survival between younger (2–3‐yr old) and older (≥4‐yr old) branch‐antlered males or zone differences for yearling males. A model with zone differences for branch‐antlered males was the second ranked model and accounted for 14% of the available model weight. From the best‐supported models, we estimated annual survival for yearling males at 0.41 (95% CI: 0.29–0.53). We estimated pooled adult female survival at 0.80 (95% CI: 0.64–0.93); when an age‐class effect was included, point estimates were higher for prime‐aged females (2–11 yr: S = 0.81 [0.70–0.88]) than for older females (≥12 yr: S = 0.72 [0.56–0.83]), but confidence intervals broadly overlapped. Only 1 of 7 models with a female age effect on survival was among the competitive models. For branch‐antlered males, survival ranged 0.80–0.85, depending on whether zone variation was modeled. We recorded 78 deaths of radiomarked elk. Human‐caused deaths (n = 55) predominated among causes and most were of yearling males killed during state‐sanctioned hunts (n = 28). Most subadult male deaths were from tribal hunting (n = 5), and most mature males died from natural causes (n = 6) and tribal hunting (n = 5). We detected few illegal kills (n = 4). Our results suggest that increased enforcement effectively reduced poaching, that unreported tribal harvest was not a trivial source of mortality, and that spike‐only general seasons were effective in recruiting branch‐antlered males. © 2011 The Wildlife Society.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.